Rowan Chapman Net Worth

The estimated Net Worth of Rowan E Chapman is at least $1.96 Million dollars as of 28 May 2024. Rowan Chapman owns over 4,856 units of Natera Inc stock worth over $619,769 and over the last 5 years he sold NTRA stock worth over $730,944. In addition, he makes $608,724 as Independent Director at Natera Inc.

Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!

Sign up

Already have an account? Sign in

or

Sign up with Google Sign up with Facebook

Rowan Chapman NTRA stock SEC Form 4 insiders trading

Rowan has made over 11 trades of the Natera Inc stock since 2020, according to the Form 4 filled with the SEC. Most recently he sold 4,856 units of NTRA stock worth $529,741 on 28 May 2024.

The largest trade he's ever made was exercising 8,000 units of Natera Inc stock on 1 March 2021 worth over $257,200. On average, Rowan trades about 2,175 units every 68 days since 2019. As of 28 May 2024 he still owns at least 5,005 units of Natera Inc stock.

You can see the complete history of Rowan Chapman stock trades at the bottom of the page.

Rowan Chapman biography

Dr. Rowan E. Chapman serves as Independent Director of the Company. Dr. Chapman is a founder, investor, and active independent board member. She most recently served as head of Johnson & Johnson Innovation, Western North America, Australia and New Zealand from January 2017 to August 2019. Prior to that, Dr. Chapman held various roles with General Electric Company (NYSE: GE) from 2012 to 2016, including as head of precision diagnostics at GE Healthcare Life Sciences, managing director of New Business Creation at GE Ventures, and head of healthcare investing at GE Ventures. Prior to that, she held operational roles in early and growth-stage startups and was a partner at Mohr Davidow Ventures for over 11 years, gaining extensive experience as a board member and board advisor for a wide variety of technology and data-enabled companies.

What is the salary of Rowan Chapman?

As the Independent Director of Natera Inc, the total compensation of Rowan Chapman at Natera Inc is $608,724. There are 9 executives at Natera Inc getting paid more, with Steven Chapman having the highest compensation of $6,200,910.

How old is Rowan Chapman?

Rowan Chapman is 49, he's been the Independent Director of Natera Inc since 2019. There are 7 older and 10 younger executives at Natera Inc. The oldest executive at Natera Inc is Herman Rosenman, 72, who is the Independent Director.

What's Rowan Chapman's mailing address?

Rowan's mailing address filed with the SEC is C/O NATERA, INC., 13011 MCCALLEN PASS BUILDING A SUITE 100, AUSTIN, TX, 78753.

Insiders trading at Natera Inc

Over the last 14 years, insiders at Natera Inc have traded over $290,138,276 worth of Natera Inc stock and bought 2,046,493 units worth $38,018,986 . The most active insiders traders include Matthew Rabinowitz, James Healy, and Roelof Botha. On average, Natera Inc executives and independent directors trade stock every 9 days with the average trade being worth of $3,415,231. The most recent stock trade was executed by Steven Leonard Chapman on 15 August 2024, trading 5,583 units of NTRA stock currently worth $663,875.

What does Natera Inc do?

natera is a san carlos, ca-based company that is driven by a passion for elevating the science and utility of prenatal testing. the advent of the information age has created a paradigm shift in the fields of computing and informatics. surprisingly, medical diagnostics have been slow to integrate these advances into genetic testing. until natera. from conception to delivery, natera is pioneering next-generation accuracy and reliability in preconception and prenatal genetic testing services, enabling couples to be informed about their pregnancy each step of the way. the company offers a wide range of tests from preimplantation genetic diagnosis (pgd) for ivf to breakthrough advances in the field of non-invasive prenatal testing (nipt). using advances from the human genome project and powered by sophisticated proprietary bioinformatic algorithms, natera’s comprehensive portfolio of tests, proven science, and experienced genetic counseling services deliver the most accurate results in the

Complete history of Rowan Chapman stock trades at Natera Inc

Natera Inc executives and stock owners

Natera Inc executives and other stock owners filed with the SEC include:

• Steven Chapman,
  President, Chief Executive Officer, Director
• Robert Schueren,
  Chief Operating Officer
• Michael Brophy,
  Chief Financial Officer
• Matthew Rabinowitz,
  Executive Chairman of the Board, Co-Founder
• Steve Leonard Chapman,
  CEO, Pres & Director
• Jonathan Sheena,
  Co-Founder, Chief Technology Officer, Director
• Robert A. Schueren,
  Chief Operating Officer
• Steve Chapman,
  CEO, Pres & Director
• Michael Brophy,
  Chief Financial Officer
• Rowan Chapman,
  Independent Director
• Dr. Matthew Rabinowitz Ph.D.,
  Co-Founder & Exec. Chairman
• Gail Marcus,
  Independent Director
• Roelof Botha,
  Lead Independent Director
• Todd Cozzens,
  Independent Director
• James Healy,
  Independent Director
• Herman Rosenman,
  Independent Director
• Roy Baynes,
  Independent Director
• Jonathan Sheena,
  Co-Founder & Director
• Monica Bertagnolli,
  Independent Director
• Rishi Kacker,
  Chief Technology Officer
• Paul Greenland,
  VP of Corp. Marketing
• Dr. Ramesh Hariharan,
  VP of Marketing & Medical Education
• Phil Grinnell,
  VP of Sales
• Daniel Rabinowitz L.L.M., LL.M.,
  Sec. & Gen. Counsel
• Eric A. Evans,
  Chief Scientific Officer
• John Steuart,
  Director
• John Fesko,
  PRESIDENT, CHIEF BUS. OFFICER
• Creek Ventures L P Claremon...,
  
• Solomon Moshkevich,
  PRESIDENT, CLINICALDIAGNOSTICS
• Creek Ventures L P Claremon...,
  
• Creek Ventures L P Claremon...,
  
• Venture Partners Viii Lp Li...,
  
• Xii Management Llcsequoia C...,
  
• Daniel Rabinowitz,
  SEC. AND CHIEF LEGAL OFFICER
• Herm Rosenman,
  
• Brinkley Ruth Williams,